Latest Articles
- What is the optimal strategy for colon cancer surveillance in patients with ulcerative colitis?
In view of the increased risk, these patients need to undergo colonoscopy on a regular basis—and fairly frequently.
- COX 2-selective NSAIDs: Biology, promises, and concerns
A new family of nonsteroidal anti-inflammatory drugs promises to be substantially safer than current agents, but should not be assumed to be totally without adverse effects.
- New insulin replacement technologies: Overcoming barriers to tight glycemic control
Several new pharmacologic and technologic innovations should make life easier for diabetic patients who require insulin. With an illustration depicting new options that are either available or under development.
- Colorectal cancer screening: Making sense of the different guidelines
Colon cancer screening is dismally underused. A review of the guidelines from three different groups, with recommendations in areas of controversy.
- Resuscitating the exercise stress test
Old does not necessarily mean obsolete. The exercise stress test can still provide useful information, provided we ask the right questions.
- Gastrointestinal and renal involvement in vasculitis: Management strategies in Henoch-Schönlein purpura
Available evidence favors a short course of oral corticosteroids for gastrointestinal involvement and aggressive immunotherapy for progressive HSP nephritis, but the data are sparse.
- Hypersensitivity syndrome to antiepileptic drugs: A review including new anticonvulsants
How to recognize this potentially fatal adverse reaction and choose a safe substitute drug.
- Should all diabetic patients take ACE inhibitors, even those without proteinuria?
To give ACE inhibitors to all diabetic patients would be premature, but these agents have clear indications in some patients.
- Management of perimenopause: Focus on alternative therapies
What unregulated over-the-counter products are your patients taking? What do these products do?